StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.42−0.06 (-12.04%)

Close on Nov 17, 2026Market cap $29.10MP/E –Yield –

Telomir Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Telomir Pharmaceuticals's market cap was $40.92M on Nov 11, 2026, against $45.33M a year earlier. Over the last 3 years it ranged from $37.20M to $259.49M, with a median of $75.89M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$40.92M-9.1%
2025Dec 31, 2025$45.00M-63.1%
2024Dec 31, 2024$121.99M–

More Telomir Pharmaceuticals figures

See a number that looks wrong?